GB2197199B - Medicament for treatment of pregnancy-induced hypertension. - Google Patents

Medicament for treatment of pregnancy-induced hypertension.

Info

Publication number
GB2197199B
GB2197199B GB8726517A GB8726517A GB2197199B GB 2197199 B GB2197199 B GB 2197199B GB 8726517 A GB8726517 A GB 8726517A GB 8726517 A GB8726517 A GB 8726517A GB 2197199 B GB2197199 B GB 2197199B
Authority
GB
United Kingdom
Prior art keywords
pregnancy
medicament
treatment
induced hypertension
hypertension
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
GB8726517A
Other versions
GB2197199A (en
GB8726517D0 (en
Inventor
Michael John England
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EFAMED
Original Assignee
EFAMED
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EFAMED filed Critical EFAMED
Publication of GB8726517D0 publication Critical patent/GB8726517D0/en
Publication of GB2197199A publication Critical patent/GB2197199A/en
Application granted granted Critical
Publication of GB2197199B publication Critical patent/GB2197199B/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
GB8726517A 1986-11-13 1987-11-12 Medicament for treatment of pregnancy-induced hypertension. Expired - Fee Related GB2197199B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA868623 1986-11-13

Publications (3)

Publication Number Publication Date
GB8726517D0 GB8726517D0 (en) 1987-12-16
GB2197199A GB2197199A (en) 1988-05-18
GB2197199B true GB2197199B (en) 1991-04-03

Family

ID=25578634

Family Applications (1)

Application Number Title Priority Date Filing Date
GB8726517A Expired - Fee Related GB2197199B (en) 1986-11-13 1987-11-12 Medicament for treatment of pregnancy-induced hypertension.

Country Status (3)

Country Link
AU (1) AU601238B2 (en)
GB (1) GB2197199B (en)
HK (1) HK8994A (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8819110D0 (en) * 1988-08-11 1988-09-14 Norsk Hydro As Antihypertensive drug & method for production
DK0661049T3 (en) * 1993-12-31 2000-02-14 Univ Limburg Use of Essential Fatty Acid Compositions
SE0202188D0 (en) 2002-07-11 2002-07-11 Pronova Biocare As A process for decreasing environmental pollutants in an oil or a fat, a volatile fat or oil environmental pollutants decreasing working fluid, a health supplement, and an animal feed product
EP2295529B2 (en) 2002-07-11 2022-05-18 Basf As Use of a volatile environmental pollutants-decreasing working fluid for decreasing the amount of pollutants in a fat for alimentary or cosmetic use

Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097602A (en) * 1974-11-29 1978-06-27 Silver Melvin J Method of inhibiting blood platelet aggregation
GB2033745A (en) * 1978-05-26 1980-05-29 Wellcome Found Fatty acid and derivatives thereof in treatment or prophylaxis of thrombo-embolic conditions
GB1604554A (en) * 1978-05-26 1981-12-09 Dyerberg J Pharmaceutical and food formulations
GB2104907A (en) * 1981-07-16 1983-03-16 Kureha Chemical Ind Co Ltd Cyclodextrin inclusion compound
GB2134782A (en) * 1982-09-22 1984-08-22 Sentrachem Ltd Anti-cancer compositions containing higher fatty acids
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
GB2146650A (en) * 1983-08-08 1985-04-24 Hayashibara Biochem Lab Inclusion compound of eicosapentaenoic acid and food product containing the same
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
EP0175468A2 (en) * 1984-08-10 1986-03-26 Sentrachem Limited Eicosanoids for use in cancer therapy
EP0222483A2 (en) * 1985-10-02 1987-05-20 Efamol Holdings Plc Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of endometriosis
EP0232501A1 (en) * 1985-12-19 1987-08-19 Chimicasa Gmbh Pharmaceutical preparation for the treatment of lipid metabolism disorders (hyperlipoproteinemia)
EP0218460B1 (en) * 1985-10-02 1993-01-13 Efamol Holdings Plc Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus.

Patent Citations (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4097602A (en) * 1974-11-29 1978-06-27 Silver Melvin J Method of inhibiting blood platelet aggregation
GB2033745A (en) * 1978-05-26 1980-05-29 Wellcome Found Fatty acid and derivatives thereof in treatment or prophylaxis of thrombo-embolic conditions
GB1604554A (en) * 1978-05-26 1981-12-09 Dyerberg J Pharmaceutical and food formulations
GB2104907A (en) * 1981-07-16 1983-03-16 Kureha Chemical Ind Co Ltd Cyclodextrin inclusion compound
US4513008A (en) * 1982-07-30 1985-04-23 The Vinoxen Company, Inc. Virucidal compositions and therapy
GB2134782A (en) * 1982-09-22 1984-08-22 Sentrachem Ltd Anti-cancer compositions containing higher fatty acids
GB2146650A (en) * 1983-08-08 1985-04-24 Hayashibara Biochem Lab Inclusion compound of eicosapentaenoic acid and food product containing the same
US4526902A (en) * 1983-10-24 1985-07-02 Century Laboratories, Inc. Combined fatty acid composition for treatment or prophylaxis of thrombo-embolic conditions
EP0175468A2 (en) * 1984-08-10 1986-03-26 Sentrachem Limited Eicosanoids for use in cancer therapy
EP0222483A2 (en) * 1985-10-02 1987-05-20 Efamol Holdings Plc Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of endometriosis
EP0218460B1 (en) * 1985-10-02 1993-01-13 Efamol Holdings Plc Use of gamma-linolenic acid and related compounds for the manufacture of a medicament for the treatment of complications of diabetes mellitus.
EP0232501A1 (en) * 1985-12-19 1987-08-19 Chimicasa Gmbh Pharmaceutical preparation for the treatment of lipid metabolism disorders (hyperlipoproteinemia)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
JP 60/123414 & Chem.Abs. 103(26),220814d *
Martindale, The Extra Pharmacopoeia, 28th Edition (1982), page 1706 entry no. 12685-f *

Also Published As

Publication number Publication date
HK8994A (en) 1994-02-04
AU601238B2 (en) 1990-09-06
GB2197199A (en) 1988-05-18
AU8113787A (en) 1988-05-19
GB8726517D0 (en) 1987-12-16

Similar Documents

Publication Publication Date Title
OA08581A (en) Treatment of diseases caused by retroviruses.
GB2203979A (en) Surgical microstapler
GB8621869D0 (en) Treatment
EP0215956A4 (en) Composition for treating skin disease.
ZA879505B (en) Flyslag treatment
GB2197199B (en) Medicament for treatment of pregnancy-induced hypertension.
GB8714972D0 (en) Medical treatment
GB2200284B (en) Electrode for skin treatment
SG115493G (en) Medicament for treatment of pregnancy-induced hypertension
GB8617623D0 (en) Treatment
GB8712928D0 (en) Passivation treatment
PT80481B (en) Tetrahydronaphthalenols for the treatment of hypertension
IE873394L (en) Material for treatment of ammonia.
GB8615669D0 (en) Treatment
IE880151L (en) Method for treatment of hyperacidity.
IE862743L (en) Derivatives of human ó-interferon.
GB8619094D0 (en) Treatment
GB8629641D0 (en) Treatment
GB8619488D0 (en) Treatment
GB8616275D0 (en) Treatment
GB8613415D0 (en) Treatment
GB8608919D0 (en) Treatment
GB8601120D0 (en) Treatment
GB8619946D0 (en) Treatment
GB8616274D0 (en) Treatment

Legal Events

Date Code Title Description
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19961112